Search
TN-301
go.drugbank.com/drugs/DB32867ExperimentalTN-301 is a small-molecule histone deacetylase 6 inhibitor.
Zeteletinib
go.drugbank.com/drugs/DB21491InvestigationalThe usage of the INN stem '-tinib' in the name indicates that Zeteletinib is a tyrosine kinase inhibitor.
Resomelagon
go.drugbank.com/drugs/DB21579InvestigationalThe usage of the INN stem '-melagon' in the name indicates that Resomelagon is a non-peptidic melanocortin receptor agonist.
Basroparib
go.drugbank.com/drugs/DB21582InvestigationalThe usage of the INN stem '-parib' in the name indicates that Basroparib is a poly-ADP-Ribose polymerase inhibitor.
Docirbrutinib
go.drugbank.com/drugs/DB21606InvestigationalThe usage of the INN stem '-brutinib' in the name indicates that Docirbrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.
Bimokalner
go.drugbank.com/drugs/DB21717InvestigationalThe usage of the INN stem '-kalner' in the name indicates that Bimokalner is a opener of calcium-activated (maxi-K) K+-channel.
Ocadusertib
go.drugbank.com/drugs/DB21732InvestigationalThe usage of the INN stem '-sertib' in the name indicates that Ocadusertib is a serine/threonine kinase inhibitor.
Enlonstobart
go.drugbank.com/drugs/DB21890Investigational[A274486] It targets the programmed cell death protein 1 (PD-1), is being developed by the CSPC Pharmaceutical Group for the treatment of advanced cervical cancer and other solid tumours.
Rusalatide acetate
go.drugbank.com/drugs/DB11668InvestigationalChrysalin has been used in trials studying the treatment of Radius Fracture.
Equol
go.drugbank.com/drugs/DB11674InvestigationalEquol has been used in trials studying the treatment of Breast Cancer.